|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
238,172,000 |
Market
Cap: |
2.86(B) |
Last
Volume: |
2,152,571 |
Avg
Vol: |
1,324,858 |
52
Week Range: |
$11.61 - $23.84 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : 12.3 |
Insider 6 Months : 12.3 |
Insider 3/6 Months : 24.3 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Neogen and subsidiaries develop, manufacture and market a range of products and services dedicated to food and animal safety. Co.'s segments are: Food Safety, which is engaged in the production and marketing of diagnostic test kits and complementary products marketed to food and feed producers and processors to detect dangerous and/or unintended substances in food and animal feed; and Animal Safety, which is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, a range of agricultural biosecurity products such as rodenticides, cleaners, disinfectants and insecticides, and genomics services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
53,000 |
53,000 |
76,000 |
143,100 |
Total Buy Value |
$662,087 |
$662,087 |
$1,009,714 |
$2,211,696 |
Total People Bought |
4 |
4 |
5 |
9 |
Total Buy Transactions |
4 |
4 |
7 |
17 |
Total Shares Sold |
0 |
0 |
6,359 |
6,359 |
Total Sell Value |
$0 |
$0 |
$109,734 |
$109,734 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
4 |
4 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Morrical Terri A |
Senior Director, Special Proje |
|
2021-04-26 |
4 |
S |
$96.97 |
$186,381 |
D/D |
(1,921) |
37,575 |
|
54% |
|
Morrical Terri A |
Senior Director, Special Proje |
|
2021-04-26 |
4 |
OE |
$62.70 |
$50,160 |
D/D |
800 |
38,375 |
|
- |
|
Morrical Terri A |
Senior Director, Special Proje |
|
2021-04-23 |
4 |
OE |
$62.70 |
$70,287 |
D/D |
1,121 |
38,696 |
|
- |
|
Quinlan Steven J. |
Vice President & CFO |
|
2021-04-14 |
4 |
S |
$93.93 |
$1,221,153 |
D/D |
(13,001) |
13,470 |
|
53% |
|
Quinlan Steven J. |
Vice President & CFO |
|
2021-04-14 |
4 |
OE |
$60.43 |
$785,618 |
D/D |
13,001 |
26,471 |
|
- |
|
Lilly Jason Warren |
Vice President, International |
|
2021-04-13 |
4 |
S |
$92.25 |
$91,604 |
D/D |
(993) |
10,353 |
|
53% |
|
Boehm William T |
Director |
|
2021-03-31 |
4 |
S |
$88.25 |
$176,500 |
D/D |
(2,000) |
10,479 |
|
52% |
|
Boehm William T |
Director |
|
2021-03-31 |
4 |
OE |
$59.13 |
$118,260 |
D/D |
2,000 |
12,479 |
|
- |
|
Adent John Edward |
President & CEO |
|
2021-03-31 |
4 |
S |
$87.99 |
$3,560,395 |
D/D |
(40,464) |
20,080 |
|
52% |
|
Adent John Edward |
President & CEO |
|
2021-03-31 |
4 |
OE |
$62.70 |
$2,554,658 |
D/D |
40,464 |
60,544 |
|
- |
|
Quinlan Steven J. |
Vice President & CFO |
|
2021-03-31 |
4 |
S |
$88.07 |
$1,321,058 |
D/D |
(15,000) |
13,470 |
|
52% |
|
Quinlan Steven J. |
Vice President & CFO |
|
2021-03-31 |
4 |
OE |
$60.43 |
$906,413 |
D/D |
15,000 |
28,470 |
|
- |
|
Adent John Edward |
President & CEO |
|
2021-03-30 |
4 |
S |
$87.09 |
$830,486 |
D/D |
(9,536) |
20,080 |
|
50% |
|
Adent John Edward |
President & CEO |
|
2021-03-30 |
4 |
OE |
$62.70 |
$597,907 |
D/D |
9,536 |
29,616 |
|
- |
|
Adent John Edward |
President & CEO |
|
2021-03-30 |
4 |
OE |
$62.70 |
$254,834 |
D/D |
4,000 |
20,080 |
|
- |
|
Morrical Terri A |
Senior Director, Special Proje |
|
2021-03-29 |
4 |
S |
$87.99 |
$52,795 |
D/D |
(600) |
37,575 |
|
49% |
|
Morrical Terri A |
Senior Director, Special Proje |
|
2021-03-29 |
4 |
OE |
$40.46 |
$24,278 |
D/D |
600 |
38,175 |
|
- |
|
Papesh G Bruce |
Director |
|
2021-03-25 |
4 |
S |
$85.42 |
$597,957 |
D/D |
(7,000) |
36,261 |
|
49% |
|
Papesh G Bruce |
Director |
|
2021-03-25 |
4 |
OE |
$59.13 |
$436,150 |
D/D |
7,000 |
43,261 |
|
- |
|
Lilly Jason Warren |
Vice President, International |
|
2021-02-05 |
4 |
S |
$85.23 |
$193,052 |
D/D |
(2,265) |
11,346 |
|
46% |
|
Papesh G Bruce |
Director |
|
2021-01-13 |
4 |
S |
$83.40 |
$2,502,063 |
D/D |
(30,000) |
36,261 |
|
-10% |
|
Papesh G Bruce |
Director |
|
2021-01-13 |
4 |
OE |
$17.07 |
$839,520 |
D/D |
30,000 |
66,261 |
|
- |
|
Adent John Edward |
President & CEO |
|
2021-01-07 |
4 |
OE |
$84.18 |
$1,683,694 |
D/D |
20,000 |
16,080 |
|
- |
|
Adent John Edward |
President & CEO |
|
2021-01-07 |
4 |
OE |
$51.29 |
$1,025,850 |
D/D |
20,000 |
36,080 |
|
- |
|
Quinlan Steven J. |
Vice President & CFO |
|
2021-01-07 |
4 |
S |
$84.49 |
$788,526 |
D/D |
(9,333) |
13,470 |
|
-8% |
|
523 Records found
|
|
Page 3 of 21 |
|
|